Skip to main content
. 2024 Oct 28;12(10):E1220–E1229. doi: 10.1055/a-2406-7492

Table 2 Baseline characteristics of patients undergoing postprocedural bleeding prevention.

EMR, endoscopic mucosal resection; ERCP, endoscopic retrograde cholangiopancreatography; ESD, endoscopic submucosal dissection; GAVE, gastric antral vascular ectasia; KAR, knife assisted resection; SD, standard deviation; WOPN, walled-off pancreatic necrosis.
Number of patients 310
Sex (n;%) Male 165 (53.2)
Female 145 (46.8)
Age (mean, SD) 69 ± 12.2
Comorbidities (n,%) None 107 (34.5)
Cardiovascular 178 (57.4)
Diabetes 40 (12.9)
Renal disease 13 (4.2)
Liver disease 7 (2.3)
Antithrombotic therapy (n,%) Antiplatelet 57 (18.4)
Anticoagulant 32 (10.3)
Both 4 (1.3)
Bleeding location (n,%) Upper location 103 (33.2)

  • Esophagus 10 (3.2)

  • Stomach 53 (17.1)

  • Duodenum 22 (7.1)

  • Ampulla 18 (5.8)
Lower location 200 (64.5)

  • Ileocecal valve 2 (0.6)

  • Caecum 20 (6.5)

  • Right colon 32 (10.3)

  • Transverse colon 11 (3.6)

  • Left colon 27 (8.7)

  • Rectum 108 (34.8)
Biliopancreatic 7 (2.3)
Endoscopic procedure (n,%) ESD 172 (55.5)

  • Esophageal ESD 6 (1.9)

  • Gastric ESD 42 (13.6)

  • Cecal ESD 5 (1.6)

  • Right colon ESD 7 (2.3)

  • Transverse colon ESD 6 (1.9)

  • Left colon ESD 10 (3.2)

  • Rectal ESD 96 (31)
EMR 94 (30.3)

  • Esophageal EMR 3 (1)

  • Gastric EMR 2 (0.6)

  • Duodenal EMR 20 (6.5)

  • Ileocecal valve EMR 2 (0.6)

  • Cecal EMR 15 (4.9)

  • Right colon EMR 25 (8.1)

  • Transverse colon EMR 5 (1.6)

  • Left colon EMR 13 (4.2)

  • Rectal EMR 9 (2.9)
ERCP 8 (2.6)
Papillectomy 8 (2.6)
KAR 8 (2.6)

  • Esophageal KAR 1 (0.3)

  • Gastric KAR 3 (1)

  • Left colon KAR 4 (1.3)
WOPN drainage 7 (2.3)
Treatment of GAVE 4 (1.3)
Polypectomy 3 (1)

  • Duodenal polypectomy 2 (0.6)

  • Rectal polypectomy 1 (0.3)
Treatment of gastric mass lesion 3 (1)
Treatment of radiation proctopathy 2 (0.6)
Pneumatic anastomotic dilation 1 (0.3)